Stroke is a major global cause of morbidity and mortality and is frequently complicated by early cardiovascular events, collectively referred to as stroke-heart syndrome (SHS)[1,2]. The SHS encompasses a spectrum of early cardiovascular complications that occur within 30 days of an acute ischaemic stroke, involving either the emergence of new cardiac conditions or the destabilization of pre-existing ones. These include acute myocardial infarction (AMI), heart failure (HF), systolic dysfunction - including Takotsubo cardiomyopathy - arrhythmias (such as atrial fibrillation [AF] and other electrocardiographic abnormalities), and sudden cardiac death[2–5].
